心肺：美國心衰護士協會的官方出版物《急性和危重病護理雜志》，介紹了有關急性和危重病患者以及慢性心臟或肺疾病患者護理的技術、進展、調查和觀察的原始同行評審文章。該雜志的急癥護理文章重點關注住院患者的護理，包括那些在危重和急癥護理環境中的患者。因為大多數在急癥和重癥監護室住院的患者都有慢性病，我們也對慢性危重病、慢性心肺疾病患者的護理、他們的康復和疾病預防感興趣。《心臟衰竭雜志》的文章集中討論了該病患者護理的各個方面。受歡迎的手稿與人類壽命中的人口有關。我們有興趣在各種環境下發表代表廣泛科學和臨床實踐的文章，因為它與我們的目標人群有關。由于衛生保健和衛生科學是全球性的、跨學科的、跨學科的和跨學科的，我們鼓勵作者提交反映這些觀點的手稿。許多文章也為護士在臨床實踐中應用研究成果提供了框架。我們出版原始研究、病例報告、評論和觀察，這些都是科學和臨床實踐的前沿。關于護理成本、患者教育和健康政策的討論與我們的重點有關。特別歡迎設計良好的臨床試驗報告和系統回顧。

Heart & Lung: The Journal of Acute and Critical Care, the official publication of The American Association of Heart Failure Nurses, presents original, peer-reviewed articles on techniques, advances, investigations, and observations related to the care of patients with acute and critical illness and patients with chronic cardiac or pulmonary disorders.The Journal''s acute care articles focus on the care of hospitalized patients, including those in the critical and acute care settings. Because most patients who are hospitalized in acute and critical care settings have chronic conditions, we are also interested in the chronically critically ill, the care of patients with chronic cardiopulmonary disorders, their rehabilitation, and disease prevention. The Journal''s heart failure articles focus on all aspects of the care of patients with this condition. Manuscripts that are relevant to populations across the human lifespan are welcome.We are interested in publishing articles representing a broad range of science and clinical practice in a variety of settings as it pertains to our target population. Because health care and the health sciences are global, interdisciplinary, multidisciplinary, and transdisciplinary, we encourage authors to submit manuscripts that reflect these perspectives. Many articles also provide nurses with a framework for applying research results in clinical practice.We publish original research, case reports, reviews, and observations that are on the cutting edge of science and clinical practice. Discussions of costs of care, patient education, and health policy are relevant to our focus. Reports of well-designed clinical trials and systematic reviews are especially welcome.